Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004982242 | SCV005587504 | uncertain significance | Inborn genetic diseases | 2024-11-07 | criteria provided, single submitter | clinical testing | The c.894A>T (p.E298D) alteration is located in exon 4 (coding exon 3) of the ESCO2 gene. This alteration results from a A to T substitution at nucleotide position 894, causing the glutamic acid (E) at amino acid position 298 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |